Neogen TC
Songpadong
About Neogen TC
Neogentc is developing an anti-cancer immune T-cell therapy based on a new antigen discovery platform that goes beyond inaccurate predictions and an innovative immune cell therapy-based technology that binds to actual immune cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $13.4M
- Last round: Series Unknown (Jan 2022)
- Website: neogentc.com
- Phone: +82 2 3010 8451
Industries & Categories
Health Care, Medical, Pharmaceutical, Product Research
Canonical: https://fsome.com/organization/neogen-tc-127828 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.